5-Amino-1MQ is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
5-Amino-1MQ (5-Amino-1-Methyl-Quinolinium) is researched primarily for fat oxidation, metabolic flexibility, improved grip strength, increased endurance, reduced muscle recovery time, anti-aging effects. First-in-class NNMT inhibitor — the only compound that boosts NAD+ by preventing its precursor from being degraded, rather than simply supplementing more precursor. It belongs to the Small molecule NNMT inhibitor category of compounds.
What Is 5-Amino-1MQ?
5-Amino-1MQ (5-Amino-1-Methyl-Quinolinium) is a Small molecule NNMT inhibitor. Synthetic compound designed to inhibit nicotinamide N-methyltransferase (NNMT) and boost NAD+ synthesis through the salvage pathway.
First-in-class NNMT inhibitor — the only compound that boosts NAD+ by preventing its precursor from being degraded, rather than simply supplementing more precursor. It has attracted significant research interest for its potential effects on fat oxidation, metabolic flexibility, improved grip strength, increased endurance, reduced muscle recovery time, anti-aging effects.
How Does 5-Amino-1MQ Produce These Benefits?
Selectively inhibits the NNMT enzyme, which normally degrades nicotinamide and prevents NAD+ synthesis. By blocking NNMT, it frees nicotinamide for NAD+ production via the salvage pathway and activates SIRT1 longevity pathways. Also stimulates AMP-activated protein kinase (AMPK) in adipocytes and myocytes, promoting mitochondrial biogenesis and fat oxidation.
This multi-pathway activity is why 5-Amino-1MQ shows potential across several different applications rather than being limited to a single use case.
Can 5-Amino-1MQ Help With Fat Oxidation?
Research suggests 5-Amino-1MQ may support fat oxidation through its small molecule nnmt inhibitor activity. Improved grip strength by ~60% when combined with exercise in aged mice. Increased endurance and reduced recovery time in animal models. Preclinical evidence shows protection against diet-induced weight gain. No human clinical trials completed.
Protocols targeting fat oxidation typically use 150-500 mcg subcutaneous, 50-100 mg oral administered once to twice daily for 4-12 weeks.
Can 5-Amino-1MQ Help With Metabolic Flexibility?
Research suggests 5-Amino-1MQ may support metabolic flexibility through its small molecule nnmt inhibitor activity. Improved grip strength by ~60% when combined with exercise in aged mice. Increased endurance and reduced recovery time in animal models. Preclinical evidence shows protection against diet-induced weight gain. No human clinical trials completed.
Protocols targeting metabolic flexibility typically use 150-500 mcg subcutaneous, 50-100 mg oral administered once to twice daily for 4-12 weeks.
Can 5-Amino-1MQ Help With Improved Grip Strength?
Research suggests 5-Amino-1MQ may support improved grip strength through its small molecule nnmt inhibitor activity. Improved grip strength by ~60% when combined with exercise in aged mice. Increased endurance and reduced recovery time in animal models. Preclinical evidence shows protection against diet-induced weight gain. No human clinical trials completed.
Protocols targeting improved grip strength typically use 150-500 mcg subcutaneous, 50-100 mg oral administered once to twice daily for 4-12 weeks.
Can 5-Amino-1MQ Help With Increased Endurance?
Research suggests 5-Amino-1MQ may support increased endurance through its small molecule nnmt inhibitor activity. Improved grip strength by ~60% when combined with exercise in aged mice. Increased endurance and reduced recovery time in animal models. Preclinical evidence shows protection against diet-induced weight gain. No human clinical trials completed.
Protocols targeting increased endurance typically use 150-500 mcg subcutaneous, 50-100 mg oral administered once to twice daily for 4-12 weeks.
Can 5-Amino-1MQ Help With Reduced Muscle Recovery Time?
Research suggests 5-Amino-1MQ may support reduced muscle recovery time through its small molecule nnmt inhibitor activity. Improved grip strength by ~60% when combined with exercise in aged mice. Increased endurance and reduced recovery time in animal models. Preclinical evidence shows protection against diet-induced weight gain. No human clinical trials completed.
Protocols targeting reduced muscle recovery time typically use 150-500 mcg subcutaneous, 50-100 mg oral administered once to twice daily for 4-12 weeks.
Can Stacking Enhance 5-Amino-1MQ Benefits?
Pairs well with NAD+ precursors (NMN, NR) for synergistic metabolic enhancement, and with MOTS-C for comprehensive mitochondrial optimization.
See our 5-Amino-1MQ stacking guide for detailed combination protocols.
What Is the Bottom Line on 5-Amino-1MQ Benefits?
5-Amino-1MQ is researched for fat oxidation, metabolic flexibility, improved grip strength, increased endurance, reduced muscle recovery time, anti-aging effects. The evidence base includes: Improved grip strength by ~60% when combined with exercise in aged mice. Increased endurance and reduced recovery time in animal models. Preclinical evidence shows protection against diet-induced weight gain. No human clinical trials completed.
5-Amino-1MQ is not fda-approved. available as research chemical. not scheduled or controlled. Source from reputable vendors with third-party testing for reliable results.
Complete Guide
5-Amino-1MQ : Benefits, Dosage, Side Effects & Research
Related Reading
- 5-Amino-1MQ Dosage Guide
- 5-Amino-1MQ Side Effects
- 5-Amino-1MQ Stacking Guide
- 5-Amino-1MQ Cycle Guide
- 5-Amino-1MQ Research
- MOTS-C Complete Guide
Calculate Your 5-Amino-1MQ Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for 5-Amino-1MQ.
Open Calculator →Research-Grade Sourcing
If you're going to research 5-Amino-1MQ, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is 5-Amino-1MQ?
5-Amino-1MQ (5-Amino-1-Methyl-Quinolinium) is a Small molecule NNMT inhibitor. Synthetic compound designed to inhibit nicotinamide N-methyltransferase (NNMT) and boost NAD+ synthesis through the salvage pathway. It is researched for fat oxidation, metabolic flexibility, improved grip strength, increased endurance, reduced muscle recovery time, anti-aging effects.
What is the recommended 5-Amino-1MQ dosage?
Common dosages: 150-500 mcg subcutaneous, 50-100 mg oral administered once to twice daily via subcutaneous injection or oral. Cycle length: 4-12 weeks. Half-life: not established in humans. Use our peptide calculator for exact reconstitution math.
What are the side effects of 5-Amino-1MQ?
Good tolerability in preclinical data. No major adverse events reported. Limited human safety data — long-term effects in humans unknown.
Is 5-Amino-1MQ safe?
5-Amino-1MQ has shown a preliminary safety profile in research. Not FDA-approved. Available as research chemical. Not scheduled or controlled. All research should follow appropriate safety protocols.